-+ 0.00%
-+ 0.00%
-+ 0.00%

NeuPath Q2 FY26 adjusted EBITDA drops 23% to CAD 1.7 million; revenue falls 2% to CAD 23.2 million

PUBT·08/13/2026 11:30:33
Listen to the news
NeuPath Q2 FY26 adjusted EBITDA drops 23% to CAD 1.7 million; revenue falls 2% to CAD 23.2 million
  • NeuPath Health reported Q2 revenue of CAD 23.2 million, down 2% from the prior-year quarter.
  • IFRS net income rose to CAD 1.68 million from CAD 342,000 a year earlier.
  • Adjusted EBITDA fell 23% to CAD 1.7 million, reflecting a prior-year CAD 1.9 million one-time reimbursement-related payment.
  • Physical capacity utilization increased to 56% from 52% in the prior-year quarter.
  • CEO Stephen Lemieux cited record patient visits; six new physicians joined after quarter-end to expand services at existing facilities.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. NeuPath Health Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20260813717132) on August 13, 2026, and is solely responsible for the information contained therein.